AskGene Pharma Competitors and Similar CompaniesClear all

AskGene Pharma's competitors and similar companies include ASLAN Pharmaceuticals, NiKang Therapeutics, AstraZeneca and Telix Pharmaceuticals.

	AskGene Pharma AskGene Pharma is a developer of prodrugs for oncology, ophthalmology, and autoimmune disease treatment.	ASLAN Pharmaceuticals ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market.	NiKang Therapeutics NiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines.	AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.	Telix Pharmaceuticals Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care.
Founding Date	Founding Date 2012	Founding Date N/A	Founding Date 2017	Founding Date 1999	Founding Date 2015
Type	Type Private	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma
Locations	Locations Camarillo, US HQ	Locations SG HQ Collingwood, AU	Locations Wilmington, US HQ	Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more	Locations North Melbourne, AU HQ Milton, AU Sydney, AU Herstal, BE Burnaby, CA Kyoto, JP Lancy, CH see more
Employees	Employees 910% decrease	Employees 35	Employees 403% increase	Employees 94,300	Employees 415
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 2.7 b	Valuation ($) 4.6 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $12m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) $58.7b (FY, 2025)	Revenue (est.) $803.8m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $4.9b (FY, 2025)	Cost of goods $356m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $12m (FY, 2023)	Gross profit N/A	Gross profit $54.2b (FY, 2025)	Gross profit $449m (FY, 2025)
Net income	Net income N/A	Net income ($44.2m) (FY, 2023)	Net income N/A	Net income $10.2b (FY, 2025)	Net income ($7.1m) (FY, 2025)
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 23m (almost 10 years ago)	Latest funding round $ 200m (about 5 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised $ 100m	Total funding raised $ 200m	Total funding raised $ 1b	Total funding raised N/A